StockDriftsStockDriftsAbion (203400) has 31 disclosed insider purchases and 3 disclosed disposals on record, filed by 6 distinct insiders. Together those filings cover ₩9.1B ($6.3M) in reported transaction value. The earliest filing StockDrifts holds for Abion is dated 2023-12-27; the most recent is 2026-07-06. Across these filings the average return since disclosure is +0.47%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-09-14 | SELL | 주식병합 | 장기룡 Jang Ki-ryong | vice president | -52.5K | ₩3,380 | +0.0% | ₩177M ($123K) |
| 2026-09-14 | SELL | 주식병합 | 우성윤 Seongyoon Woo | vice president | -165.5K | ₩3,380 | +0.0% | ₩559M ($388K) |
| 2026-09-14 | SELL | 주식병합 | 신영기 Youngki Shin | CEO | -1.7M | ₩3,380 | +0.0% | ₩5.7B ($4.0M) |
| 2026-09-14 | SELL | 주식병합 | 텔콘RF제약 Telcon RF Pharmaceutical | - | -525.5K | ₩3,380 | +0.0% | ₩1.8B ($1.2M) |
| 2026-09-14 | SELL | 주식병합 | 텔콘RF제약 Telcon RF Pharmaceutical | - | -13.1M | ₩3,380 | +0.0% | ₩44.3B ($30.8M) |
| 2026-09-14 | SELL | 주식병합 | 이영휘 Younghwi Lee | moving | -6.5K | ₩3,380 | +0.0% | ₩22M ($15K) |
| 2026-08-11 | BUY | Market Buy | 장기룡 Jang Ki-ryong | vice president | 35.6K | ₩980 | -12.7% | ₩36M ($25K) |
| 2026-08-11 | BUY | Market Buy | 우성윤 Seongyoon Woo | vice president | 3.6K | ₩676 | +0.0% | ₩3M ($2K) |
| 2026-08-04 | BUY | Market Buy | 우성윤 Seongyoon Woo | vice president | 18.6K | ₩719 | -4.3% | ₩14M ($10K) |
| 2026-08-03 | BUY | Market Buy | 우성윤 Seongyoon Woo | vice president | 84.0K | ₩688 | +0.0% | ₩60M ($42K) |
| 2026-07-29 | BUY | Market Buy | 신영기 Youngki Shin | CEO | 105.8K | ₩636 | +8.2% | ₩77M ($53K) |
| 2026-07-28 | BUY | Market Buy | 신영기 Youngki Shin | CEO | 248.0K | ₩771 | -14.0% | ₩196M ($136K) |
| 2026-07-27 | BUY | Market Buy | 신영기 Youngki Shin | CEO | 271.3K | ₩824 | -19.5% | ₩219M ($152K) |
| 2026-07-24 | BUY | Market Buy | 신영기 Youngki Shin | CEO | 200.8K | ₩805 | -17.6% | ₩158M ($110K) |
| 2026-07-06 | BUY | Market Buy | 우성윤 Seongyoon Woo | vice president | 32.6K | ₩795 | -15.7% | ₩26M ($18K) |
| 2026-06-11 | SELL | 기타 | 신영기 Youngki Shin | CEO | -363.0K | ₩1,233 | -2.2% | ₩448M ($311K) |
| 2026-06-09 | SELL | Market Sell | 신영기 Youngki Shin | CEO | -2.6M | ₩1,340 | +6.0% | ₩3.6B ($2.5M) |
| 2026-06-08 | BUY | 기타 | 신영기 Youngki Shin | CEO | 363.0K | ₩1,235 | +2.0% | ₩448M ($311K) |
| 2026-06-08 | SELL | Market Sell | 신영기 Youngki Shin | CEO | -2.3M | ₩1,235 | -2.0% | ₩2.8B ($1.9M) |
| 2026-06-02 | BUY | Market Buy | 신영기 Youngki Shin | CEO | 95.9K | ₩1,824 | -30.9% | ₩175M ($122K) |
| 2026-06-01 | BUY | Market Buy | 신영기 Youngki Shin | CEO | 13.1K | ₩1,866 | -32.5% | ₩24M ($17K) |
| 2026-05-21 | BUY | Market Buy | 신영기 Youngki Shin | CEO | 58.3K | ₩1,908 | +4.8% | ₩111M ($77K) |
| 2026-05-20 | BUY | Market Buy | 신영기 Youngki Shin | CEO | 4.9K | ₩1,923 | +4.0% | ₩9M ($7K) |
| 2026-05-20 | SELL | Market Sell | 신영기 Youngki Shin | CEO | -1.1M | ₩1,923 | -4.0% | ₩2.1B ($1.5M) |
| 2026-05-19 | BUY | Market Buy | 신영기 Youngki Shin | CEO | 4.0K | ₩2,025 | -1.2% | ₩8M ($6K) |
| 2026-05-18 | BUY | Market Buy | 신영기 Youngki Shin | CEO | 10.8K | ₩2,010 | -0.5% | ₩22M ($15K) |
| 2026-04-27 | BUY | Market Buy | 장기룡 Jang Ki-ryong | vice president | 30.0K | ₩2,705 | -5.2% | ₩81M ($56K) |
| 2026-04-27 | BUY | Market Buy | 우성윤 Seongyoon Woo | vice president | 37.9K | ₩2,705 | -5.2% | ₩102M ($71K) |
| 2026-01-13 | SELL | Market Sell | 이영휘 Younghwi Lee | moving | -900 | ₩3,480 | +2.9% | ₩3M ($2K) |
| 2025-12-02 | BUY | 무상신주취득 | 장선미 Seonmi Jang | Managing Director | 27 | ₩4,100 | -12.6% | ₩111K ($77) |
| 2025-12-02 | BUY | PROGRAM | 우성윤 Seongyoon Woo | vice president | 13.4K | ₩4,100 | -12.6% | ₩55M ($38K) |
| 2025-12-02 | BUY | PROGRAM | 김정현 Kim Jeong-hyeon | Managing Director | 13 | ₩4,100 | -12.6% | ₩53K ($37) |
| 2025-12-02 | BUY | PROGRAM | 김종란 Kim Jong-ran | vice president | 7.4K | ₩4,100 | -12.6% | ₩30M ($21K) |
| 2025-12-02 | BUY | 무상신주취득 | 임양미 Yangmi Lim | Managing Director | 92 | ₩4,100 | -12.6% | ₩377K ($262) |
| 2025-12-02 | BUY | PROGRAM | 신영기 Youngki Shin | CEO | 3.2M | ₩4,100 | -12.6% | ₩13.0B ($9.0M) |
| 2025-12-02 | SELL | 기타 | 텔콘RF제약 Telcon RF Pharmaceutical | - | -194.6K | ₩4,100 | +12.6% | ₩798M ($554K) |
| 2025-12-02 | BUY | 무상신주취득 | 김윤범 Yunbeom Kim | Managing Director | 3.5K | ₩4,100 | -12.6% | ₩14M ($10K) |
| 2025-12-02 | BUY | PROGRAM | 텔콘RF제약 Telcon RF Pharmaceutical | - | 291.9K | ₩4,100 | -12.6% | ₩1.2B ($831K) |
| 2025-12-02 | BUY | PROGRAM | 이영휘 Younghwi Lee | moving | 4.0K | ₩4,100 | -12.6% | ₩16M ($11K) |
| 2025-12-02 | BUY | PROGRAM | 텔콘RF제약 Telcon RF Pharmaceutical | - | 7.3M | ₩4,100 | -12.6% | ₩29.9B ($20.7M) |
| 2025-12-01 | BUY | 유상신주취득 | 장선미 Seonmi Jang | Managing Director | 34 | ₩3,155 | +13.6% | ₩107K ($74) |
| 2025-12-01 | SELL | 기타 | 김종란 Kim Jong-ran | vice president | -3.5K | ₩3,155 | -13.6% | ₩11M ($8K) |
| 2025-12-01 | SELL | 기타 | 신영기 Youngki Shin | CEO | -1.6M | ₩3,155 | -13.6% | ₩5.1B ($3.6M) |
| 2025-12-01 | SELL | 기타 | 이영휘 Younghwi Lee | moving | -3.5K | ₩3,155 | -13.6% | ₩11M ($8K) |
| 2025-12-01 | SELL | 기타 | 우성윤 Seongyoon Woo | vice president | -7.4K | ₩3,155 | -13.6% | ₩23M ($16K) |
| 2025-12-01 | BUY | 유상신주취득 | 임양미 Yangmi Lim | Managing Director | 115 | ₩3,155 | +13.6% | ₩363K ($252) |
| 2025-12-01 | BUY | 유상신주취득 | 김윤범 Yunbeom Kim | Managing Director | 2.0K | ₩3,155 | +13.6% | ₩6M ($4K) |
| 2025-12-01 | SELL | 기타 | 김윤범 Yunbeom Kim | Managing Director | -1.7K | ₩3,155 | -13.6% | ₩5M ($4K) |
| 2025-12-01 | BUY | PROGRAM | 김정현 Kim Jeong-hyeon | Managing Director | 17 | ₩3,155 | +13.6% | ₩54K ($37) |
| 2025-12-01 | BUY | PROGRAM | 김종란 Kim Jong-ran | vice president | 4.2K | ₩3,155 | +13.6% | ₩13M ($9K) |
Showing the 50 most recent of 102 filings.
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.